These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30555458)

  • 21. Vasoactive intestinal peptide induces CD14+HLA-DR‑/low myeloid-derived suppressor cells in gastric cancer.
    Li G; Wu K; Tao K; Lu X; Ma J; Mao Z; Li H; Shi L; Li J; Niu Y; Xiang F; Wang G
    Mol Med Rep; 2015 Jul; 12(1):760-8. PubMed ID: 25695487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CTLA‑4 blockade combined with 5‑aza‑2'‑deoxycytidine enhances the killing effect of MAGE‑A family common antigen peptide‑specific cytotoxic T cells on breast cancer.
    Li W; Sang M; Hao X; Wu Y; Shan B
    Oncol Rep; 2020 Oct; 44(4):1758-1770. PubMed ID: 32700745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lesional CD4+ IFN-γ+ cytotoxic T lymphocytes in IgG4-related dacryoadenitis and sialoadenitis.
    Maehara T; Mattoo H; Ohta M; Mahajan VS; Moriyama M; Yamauchi M; Drijvers J; Nakamura S; Stone JH; Pillai SS
    Ann Rheum Dis; 2017 Feb; 76(2):377-385. PubMed ID: 27358392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Staphylococcal enterotoxins direct and trigger CTL killing of autologous HLA-DR+ mononuclear leukocytes and freshly prepared leukemia cells.
    Hedlund G; Dohlsten M; Lando PA; Kalland T
    Cell Immunol; 1990 Sep; 129(2):426-34. PubMed ID: 2383900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokines required for induction of histocompatibility leukocyte antigen-class I-restricted and tumor-specific cytotoxic T lymphocytes by a SART1-derived peptide.
    Matsunaga K; Nakao M; Masuoka K; Inoue Y; Gouhara R; Imaizumi T; Nishizaka S; Itoh K
    Jpn J Cancer Res; 1999 Sep; 90(9):1007-15. PubMed ID: 10551332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antigenic characterization of medullary carcinoma of the breast: HLA-DR expression in lymph node positive cases.
    Lazzaro B; Anderson AE; Kajdacsy-Balla A; Hessner MJ
    Appl Immunohistochem Mol Morphol; 2001 Sep; 9(3):234-41. PubMed ID: 11556751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of tumor-infiltrative lymphocyte subtypes alteration with neoangiogenesis before and after neoadjuvant chemotherapy treatment in breast cancer patients.
    Chan MS; Chen SF; Felizola SJ; Wang L; Nemoto N; Tamaki K; Ishida T; Chow LW; Ohuchi N; Sasano H
    Int J Biol Markers; 2014 Sep; 29(3):e193-203. PubMed ID: 24803281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased circulating immunosuppressive CD14(+)HLA-DR(-/low) cells correlate with clinical cancer stage and pathological grade in patients with bladder carcinoma.
    Yuan XK; Zhao XK; Xia YC; Zhu X; Xiao P
    J Int Med Res; 2011; 39(4):1381-91. PubMed ID: 21986138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ran, a small GTPase gene, encodes cytotoxic T lymphocyte (CTL) epitopes capable of inducing HLA-A33-restricted and tumor-reactive CTLs in cancer patients.
    Azuma K; Sasada T; Takedatsu H; Shomura H; Koga M; Maeda Y; Yao A; Hirai T; Takabayashi A; Shichijo S; Itoh K
    Clin Cancer Res; 2004 Oct; 10(19):6695-702. PubMed ID: 15475460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Granulocyte colony-stimulating factor impairs CD8(+) T cell functionality by interfering with central activation elements.
    Bunse CE; Tischer S; Lahrberg J; Oelke M; Figueiredo C; Blasczyk R; Eiz-Vesper B
    Clin Exp Immunol; 2016 Jul; 185(1):107-18. PubMed ID: 26990855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV type 1-specific cytotoxic T lymphocytes stimulate HLA class I and intercellular adhesion molecule type 1 expression and increase beta 2-microglobulin levels in vitro.
    Jassoy C; Heinkelein M; Klinker H; Walker BD
    AIDS Res Hum Retroviruses; 1994 Dec; 10(12):1685-93. PubMed ID: 7888228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The predictive value of HLA class I tumor cell expression and presence of intratumoral Tregs for chemotherapy in patients with early breast cancer.
    de Kruijf EM; van Nes JG; Sajet A; Tummers QR; Putter H; Osanto S; Speetjens FM; Smit VT; Liefers GJ; van de Velde CJ; Kuppen PJ
    Clin Cancer Res; 2010 Feb; 16(4):1272-80. PubMed ID: 20145162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lymphocyte activation markers in patients with ovarian cancer].
    Nowicka A; Rogala E; Bednarek W; Barczyński B; Wertel I; Piekarczyk W; Kotarski J
    Ginekol Pol; 2012 Oct; 83(10):737-43. PubMed ID: 23383558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Host-oriented peptide evaluation using whole blood assay for generating antigen-specific cytotoxic T lymphocytes.
    Kawabuchi Y; Yamaguchi Y; Ohshita A; Minami K; Toge T
    Anticancer Res; 2004; 24(2C):1193-200. PubMed ID: 15154646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recovery of functional cytotoxic T lymphocytes during lamivudine therapy by acquiring multi-specificity.
    Kondo Y; Asabe S; Kobayashi K; Shiina M; Niitsuma H; Ueno Y; Kobayashi T; Shimosegawa T
    J Med Virol; 2004 Nov; 74(3):425-33. PubMed ID: 15368520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytotoxicity of cord blood derived Her2/neu-specific cytotoxic T lymphocytes against human breast cancer in vitro and in vivo.
    Wang P; Munger CM; Joshi AD; Pirruccello SJ; Joshi SS
    Breast Cancer Res Treat; 2004 Jan; 83(1):15-23. PubMed ID: 14997051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer.
    García-Martínez E; Gil GL; Benito AC; González-Billalabeitia E; Conesa MA; García García T; García-Garre E; Vicente V; Ayala de la Peña F
    Breast Cancer Res; 2014 Nov; 16(6):488. PubMed ID: 25432519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [In vitro anti-leukemia activity of cord blood original cytotoxic T lymphocytes].
    Zeng LJ; Tan H
    Ai Zheng; 2005 Apr; 24(4):419-24. PubMed ID: 15820063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Elimination of leukemic CD34+ progenitor cells by using cytotoxic T lymphocytes specifically targeting WT1-derived peptide: an experimental study in vitro].
    Gu WY; Chen ZX; Qiu GQ; Hu SY; Jia L; Wu W; He J; Cen JN; He B
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3401-6. PubMed ID: 19159569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linking Transcriptomic and Imaging Data Defines Features of a Favorable Tumor Immune Microenvironment and Identifies a Combination Biomarker for Primary Melanoma.
    Gartrell-Corrado RD; Chen AX; Rizk EM; Marks DK; Bogardus MH; Hart TD; Silverman AM; Bayan CY; Finkel GG; Barker LW; Komatsubara KM; Carvajal RD; Horst BA; Chang R; Monod A; Rabadan R; Saenger YM
    Cancer Res; 2020 Mar; 80(5):1078-1087. PubMed ID: 31948941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.